Amila Suraweera

6PUBLICATIONS
9CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Nov 02, 2023
Targeting the COMMD4-H2B protein complex in lung cancer.

Ming Tang, Joshua T Burgess, Mark Fisher

|May 29, 2021
Elevating CDCA3 levels in non-small cell lung cancer enhances sensitivity to platinum-based chemotherapy.

Katrina Kildey, Neha S Gandhi, Katherine B Sahin

|Apr 20, 2021
COMMD4 functions with the histone H2A-H2B dimer for the timely repair of DNA double-strand breaks.

Amila Suraweera, Neha S Gandhi, Sam Beard

|Mar 06, 2021
COMMD1, from the Repair of DNA Double Strand Breaks, to a Novel Anti-Cancer Therapeutic Target.

Amila Suraweera, Pascal H G Duijf, Christian Jekimovs

|May 23, 2020
Defining COMMD4 as an anti-cancer therapeutic target and prognostic factor in non-small cell lung cancer.

Amila Suraweera, Alex Duff, Mark N Adams

Pageof 1